Skip to main content
Clinical Trials/NCT05249088
NCT05249088CompletedNot Applicable

Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients: A Multicentre Feasibility Trial

Region Skane8 sites in 1 country98 target enrollmentStarted: March 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
98
Locations
8
Primary Endpoint
Difference in fluid administration

Study Overview

Brief Summary

The objectives of this feasibility trial are to assess the efficacy and feasibility of methods and procedures of a protocol purposed to compare a reduction of administration of non-resuscitation fluids to usual care in patients with septic shock.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

The clinical team caring for participants will not be blinded due to nature of the intervention. The participants, their family and health personnel responsible for outcome assessment at follow-up will be blinded to the allocation of the intervention. The steering group, author group, trial statistician, outcome assessors, prognosticators, statisticians, and the trial coordinating team will be blinded to group allocation.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult (≥ 18 years of age)
  • •Septic shock according to the Sepsis 3 criteria: suspected or confirmed infection AND infusion of vasopressor/inotrope to maintain mean arterial pressure of 65 mmHg or above despite adequate fluid resuscitation AND lactate of 2 mmol/L or above at any time following ICU admission when there was a simultaneous need for vasopressor/inotrope.
  • •Inclusion within 12 hours after ICU admission.

Exclusion Criteria

  • •Confirmed or suspected pregnancy

Arms & Interventions

Protocolised reduction of non-resuscitation fluids

Experimental

Participants receive non-resuscitation fluids according to a pre-defined protocol starting within two hours of randomization. The intervention is continued for the duration of the ICU admission up to a maximum of 90 days.

Intervention: Protocolised reduction of non-resuscitation fluids (Other)

Usual Care

Other

Participants receive non-resuscitation fluids according to local routines.

Intervention: Usual care (Other)

Outcomes

Primary Outcomes

Difference in fluid administration

Time Frame: Within the first three days after inclusion (days 0-3)

Total difference in litres of administered fluids between groups

Secondary Outcomes

  • Inclusion of eligible patients(During inclusion)
  • Protocol violations(Within 90 days after inclusion)
  • Proportion of participants with sufficient clinical outcome data(Within 90 days after inclusion)
  • Proportion of participants assessed by EQ5D-5L and MoCA(6 months after inclusion)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials